Danimer Scientific, Inc.
DNMR
$1.13
-$0.165-12.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -21.17% | -40.71% | -14.27% | -28.58% | 4.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.17% | -40.71% | -14.27% | -28.58% | 4.79% |
| Cost of Revenue | -15.67% | -26.56% | -10.48% | -4.59% | 29.80% |
| Gross Profit | 7.13% | -4.31% | 2.54% | -172.50% | -106.01% |
| SG&A Expenses | -55.54% | -56.08% | -59.34% | -12.03% | -12.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.99% | -40.00% | -34.64% | -7.25% | 0.62% |
| Operating Income | 39.84% | 39.71% | 42.22% | -3.75% | 0.76% |
| Income Before Tax | 44.98% | 42.35% | 25.78% | -40.36% | 58.27% |
| Income Tax Expenses | -99.57% | 103.28% | 102.22% | 104.65% | 298.31% |
| Earnings from Continuing Operations | 45.62% | 42.25% | 25.59% | -40.58% | 57.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.62% | 42.25% | 25.59% | -40.58% | 57.67% |
| EBIT | 39.84% | 39.71% | 42.22% | -3.75% | 0.76% |
| EBITDA | 52.43% | 52.71% | 55.10% | -4.55% | 10.84% |
| EPS Basic | 53.65% | 49.45% | 27.07% | -39.55% | 58.01% |
| Normalized Basic EPS | 38.51% | 50.67% | 26.92% | -38.62% | -30.49% |
| EPS Diluted | 53.65% | 49.45% | 27.07% | -39.55% | 58.01% |
| Normalized Diluted EPS | 38.51% | 50.67% | 26.92% | -38.62% | -30.49% |
| Average Basic Shares Outstanding | 17.34% | 14.25% | 2.03% | 0.74% | 0.81% |
| Average Diluted Shares Outstanding | 17.34% | 14.25% | 2.03% | 0.74% | 0.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
